MedPath

RIFADIN

RIFADIN

Discontinued
DIN Number

02092808

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02092808
AIG Number0105824001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
J04AB02 RIFAMPICIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification08:16.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

RIFAMPINActive
Strength: 300 MG
Monograph: RIFAMPIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.